Vania Manolova
6PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 15, 2026
Ferroportin inhibition attenuates pulmonary hypertension in hypoxic sickle cell disease mice.Melissa J Lucero, Saini Setua, Kiruphagaran Thangaraju
|Oct 22, 2024
Genetic iron overload aggravates, and pharmacological iron restriction improves, MDS pathophysiology in a preclinical study.Ada Antypiuk, S Zebulon Vance, Richa Sharma
|Sep 13, 2024
The oral ferroportin inhibitor vamifeport prevents liver iron overload in a mouse model of hemochromatosis.Naja Nyffenegger, Anna Flace, Ahmet Varol
|Feb 09, 2023
Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms.Jan Stetka, Marc Usart, Lucia Kubovcakova
|Jun 17, 2022
The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease.Naja Nyffenegger, Rahima Zennadi, Natarajaswamy Kalleda
|Jul 29, 2021
Oral ferroportin inhibitor vamifeport for improving iron homeostasis and erythropoiesis in β-thalassemia: current evidence and future clinical development.John Porter, Ali Taher, Vip Viprakasit
Pageof 1
Frequent Collaborators
1 joint publications
John Porter
1 joint publications
Ali Taher
1 joint publications
Vip Viprakasit
1 joint publications
Antonis Kattamis
1 joint publications
Thomas D Coates
1 joint publications
Maciej Garbowski
1 joint publications
Frank Richard
1 joint publications
M Domenica Cappellini
1 joint publications
Naja Nyffenegger
1 joint publications
Rahima Zennadi
